These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29171473)

  • 21. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
    J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
    Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Kuwahara T; Shimazu Y; Shimomura T; Watanabe S; Odagiri T;
    Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
    Ilyushina NA; Donnelly RP
    Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study.
    Leneva IA; Falynskova IN; Makhmudova NR; Poromov AA; Yatsyshina SB; Maleev VV
    J Med Virol; 2019 Apr; 91(4):588-597. PubMed ID: 30431664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
    Nabeshima S; Kashiwagi K; Ajisaka K; Masui S; Takeoka H; Ikematsu H; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):534-43. PubMed ID: 22350323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications.
    Ishaqui AA; Khan AH; Syed Sulaiman SA; Alsultan M; Khan I
    Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1763-1770. PubMed ID: 33612459
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Alagarasu K; Kaushal H; Shinde P; Kakade M; Chaudhary U; Padbidri V; Sangle SA; Salvi S; Bavdekar AR; D'costa P; Choudhary ML
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
    Trebbien R; Pedersen SS; Vorborg K; Franck KT; Fischer TK
    Euro Surveill; 2017 Jan; 22(3):. PubMed ID: 28128091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population.
    García-Ramírez RA; Ramírez-Venegas A; Quintana-Carrillo R; Camarena ÁE; Falfán-Valencia R; Mejía-Aranguré JM
    PLoS One; 2015; 10(12):e0144832. PubMed ID: 26657940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
    Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
    Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of ribavirin and reduning protects mice against severe pneumonia induced by H1N1 influenza a virus.
    Ma Y; Zhang W; Zhao Z; Li M; Liu J; Wang Y
    J Tradit Chin Med; 2016 Apr; 36(2):181-6. PubMed ID: 27400472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
    Smee DF; Wong MH; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
    Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
    J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.
    Ohgitani E; Kita M; Mazda O; Imanishi J
    Arch Virol; 2014 Feb; 159(2):267-75. PubMed ID: 23979178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.
    Martinez-Ocaña J; Olivo-Diaz A; Salazar-Dominguez T; Reyes-Gordillo J; Tapia-Aquino C; Martínez-Hernández F; Manjarrez ME; Antonio-Martinez M; Contreras-Molina A; Figueroa-Moreno R; Valdez-Vazquez R; Kawa-Karasik S; Rodríguez-Zulueta P; Flisser A; Maravilla P; Romero-Valdovinos M
    J Clin Virol; 2013 Sep; 58(1):108-13. PubMed ID: 23809475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of Oseltamivir-Resistant Influenza A(H1N1)pdm09 in Guanajuato State, Mexico from 2009 to 2012.
    Mosqueda-Gómez JL; Belaunzarán-Zamudio PF; Barba A; Córdova-Villalobos JA; Cuellar-Rodríguez JM; Ernesto Macías A
    Rev Invest Clin; 2015; 67(4):235-9. PubMed ID: 26426589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
    Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
    Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.